Migraine Headache Study
Migraine Headaches Disrupt Lives
Migraine headaches are a painful problem for millions of people worldwide. Migraine attacks can be much more severe than a “bad headache” — they can leave sufferers nearly disabled and unable to function at work, home, or in social settings. Doctors don’t understand everything about what causes migraine headaches, but they’re working to research and develop new medications for preventing them.
Doctors are Testing an Investigational Product for Preventing Migraines
STOP 301 is a new clinical research study that is looking for people who suffer from migraine headaches to test an investigational drug device product. This product is a nasal spray that’s used when you have a migraine attack. (“Investigational” means this combination product isn’t yet approved for use by the public.) Doctors are studying the investigational product to learn more about whether it may be effective for treating migraine headaches. Those who volunteer and qualify for this research study will receive all study-related medication and care at no cost.
More About STOP 301
This clinical research study is a late-phase study, which means the investigational product has been tested before. Previous studies showed positive results. However, the investigational product has not been approved for use by the public. We are conducting this study to find out if it can be approved for use by the public. Everyone who takes part in this study will receive the investigational product for migraine. There is no placebo (or “sugar pill”) being used in this study.
Important Information About the STOP 301 Study
You may qualify to participate in this study if you:
- Are 18 to 65 years of age
- Experience at least 2 migraine headaches each month
- Do not have chronic migraine
Doctors will also check other requirements to confirm that you qualify for this study.
All qualified volunteers will receive study medication and study-related medical care at no cost.
If you have migraines and are interested in participating in a clinical trial, please fill out the form below or call us at (423) 698-4584.